These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 17457717

  • 1. The workings of the amyloid diseases.
    Bellotti V, Nuvolone M, Giorgetti S, Obici L, Palladini G, Russo P, Lavatelli F, Perfetti V, Merlini G.
    Ann Med; 2007; 39(3):200-7. PubMed ID: 17457717
    [Abstract] [Full Text] [Related]

  • 2. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC.
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [Abstract] [Full Text] [Related]

  • 3. Review: immunoglobulin light chain amyloidosis--the archetype of structural and pathogenic variability.
    Bellotti V, Mangione P, Merlini G.
    J Struct Biol; 2000 Jun; 130(2-3):280-9. PubMed ID: 10940232
    [Abstract] [Full Text] [Related]

  • 4. Pathogenesis, diagnosis and treatment of systemic amyloidosis.
    Pepys MB.
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb 28; 356(1406):203-10; discussion 210-1. PubMed ID: 11260801
    [Abstract] [Full Text] [Related]

  • 5. [Amyloidosis: a model of misfolded protein disorder].
    Grateau G, Verine J, Delpech M, Ries M.
    Med Sci (Paris); 2005 Feb 28; 21(6-7):627-33. PubMed ID: 15985206
    [Abstract] [Full Text] [Related]

  • 6. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis.
    Booth DR, Sunde M, Bellotti V, Robinson CV, Hutchinson WL, Fraser PE, Hawkins PN, Dobson CM, Radford SE, Blake CC, Pepys MB.
    Nature; 1997 Feb 27; 385(6619):787-93. PubMed ID: 9039909
    [Abstract] [Full Text] [Related]

  • 7. ALys amyloidosis caused by compound heterozygosity in exon 2 (Thr70Asn) and exon 4 (Trp112Arg) of the lysozyme gene.
    Röcken C, Becker K, Fändrich M, Schroeckh V, Stix B, Rath T, Kähne T, Dierkes J, Roessner A, Albert FW.
    Hum Mutat; 2006 Jan 27; 27(1):119-20. PubMed ID: 16329101
    [Abstract] [Full Text] [Related]

  • 8. Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain.
    Davis DP, Gallo G, Vogen SM, Dul JL, Sciarretta KL, Kumar A, Raffen R, Stevens FJ, Argon Y.
    J Mol Biol; 2001 Nov 09; 313(5):1021-34. PubMed ID: 11700059
    [Abstract] [Full Text] [Related]

  • 9. Computational analysis of the S. cerevisiae proteome reveals the function and cellular localization of the least and most amyloidogenic proteins.
    Tartaglia GG, Caflisch A.
    Proteins; 2007 Jul 01; 68(1):273-8. PubMed ID: 17407164
    [Abstract] [Full Text] [Related]

  • 10. Protein aggregation and deposition: implications for ion channel formation and membrane damage.
    Kourie JI, Henry CL.
    Croat Med J; 2001 Aug 01; 42(4):359-74. PubMed ID: 11471187
    [Abstract] [Full Text] [Related]

  • 11. Proteomic typing of amyloid deposits in systemic amyloidoses.
    Lavatelli F, Vrana JA.
    Amyloid; 2011 Dec 01; 18(4):177-82. PubMed ID: 22080761
    [Abstract] [Full Text] [Related]

  • 12. Common mechanisms of amyloid oligomer pathogenesis in degenerative disease.
    Glabe CG.
    Neurobiol Aging; 2006 Apr 01; 27(4):570-5. PubMed ID: 16481071
    [Abstract] [Full Text] [Related]

  • 13. Amyloidosis.
    Sipe JD.
    Crit Rev Clin Lab Sci; 1994 Apr 01; 31(4):325-54. PubMed ID: 7888076
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Structural models of amyloid-like fibrils.
    Nelson R, Eisenberg D.
    Adv Protein Chem; 2006 Apr 01; 73():235-82. PubMed ID: 17190616
    [Abstract] [Full Text] [Related]

  • 16. Amyloidosis-associated kidney disease.
    Dember LM.
    J Am Soc Nephrol; 2006 Dec 01; 17(12):3458-71. PubMed ID: 17093068
    [Abstract] [Full Text] [Related]

  • 17. Structure, function and amyloidogenic propensity of apolipoprotein A-I.
    Obici L, Franceschini G, Calabresi L, Giorgetti S, Stoppini M, Merlini G, Bellotti V.
    Amyloid; 2006 Dec 01; 13(4):191-205. PubMed ID: 17107880
    [Abstract] [Full Text] [Related]

  • 18. Renal amyloidosis (part I).
    Ferrario F, Rastaldi MP.
    J Nephrol; 2006 Dec 01; 19(2):123-5. PubMed ID: 16736407
    [Abstract] [Full Text] [Related]

  • 19. Structures for amyloid fibrils.
    Makin OS, Serpell LC.
    FEBS J; 2005 Dec 01; 272(23):5950-61. PubMed ID: 16302960
    [Abstract] [Full Text] [Related]

  • 20. Residual structures in the acid-unfolded states of Vlambda6 proteins affect amyloid fibrillation.
    Mishima T, Ohkuri T, Monji A, Kanemaru T, Abe Y, Ueda T.
    J Mol Biol; 2009 Oct 02; 392(4):1033-43. PubMed ID: 19647748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.